(S)-tert-Butyl (1-(2-methoxybenzyl)pyrrolidin-3-yl)carbamate

Catalog No.: 
ACMDJH361
CAS No.: 
1286209-04-8
Molecular Formula: 
C17H26N2O3
Molecular Weight: 
306.41
(S)-tert-Butyl (1-(2-methoxybenzyl)pyrrolidin-3-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$297.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-tert-Butyl (1-(2-methoxybenzyl)pyrrolidin-3-yl)carbamate
IUPAC Nametert-butyl (S)-(1-(2-methoxybenzyl)pyrrolidin-3-yl)carbamate
MDL No.MFCD18378142
Molecular FormulaC17H26N2O3
Molecular Weight306.41
SMILESO=C(OC(C)(C)C)N[C@@H]1CN(CC2=CC=CC=C2OC)CC1
InChI KeyJUSOQPBZYMQCSL-AWEZNQCLSA-N
Synonym(S)-tert-Butyl 1-(2-methoxybenzyl)pyrrolidin-3-ylcarbamate;Carbamic acid, N-[(3S)-1-[(2-methoxyphenyl)methyl]-3-pyrrolidinyl]-, 1,1-dimethylethyl ester
CAS No.1286209-04-8

Synthetic Route by SureRoute

1. ACMDJH361 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLIXG127 route compound structure diagram
    ACLIXG127122536-76-9In Stock
  2. Plus
  3. ACHPFS254 route compound structure diagram
    ACHPFS254135-02-4In Stock
  4. Then
  5. ACMDJH361 route product structure diagram
    ACMDJH3611286209-04-8
Inquiry

2. ACMDJH361 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLIXG127 route compound structure diagram
    ACLIXG127122536-76-9In Stock
  2. Plus
  3. ACZKFZ969 route compound structure diagram
    ACZKFZ96952289-93-7In Stock
  4. Then
  5. ACMDJH361 route product structure diagram
    ACMDJH3611286209-04-8
Inquiry

3. ACMDJH361 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLIXG127 route compound structure diagram
    ACLIXG127122536-76-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMDJH361 route product structure diagram
    ACMDJH3611286209-04-8
Inquiry

Comments (0)